Shares of AbbVie Inc. ABBV, -1.75% slid 1.75% to $147.37 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX, -0.63% falling 0.63% to 4,132.15 and Dow Jones Industrial Average DJIA, -0.67% falling 0.67% to 32,990.12. This was the stock’s third consecutive day of losses. AbbVie Inc. closed $28.54 below its 52-week high ($175.91), which the company reached on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Pfizer Inc. PFE, -1.61% fell 1.61% to $53.04, Eli Lilly & Co. LLY, -3.10% fell 3.10% to $313.44, and AstraZeneca PLC ADR AZN, -1.36% fell 1.36% to $66.48. Trading volume (10.4 M) eclipsed its 50-day average volume of 7.5 M.